(Información remitida por la empresa firmante)
Info@nasuspharma.comNasus Pharma Ltd. Israel
https://www.nasuspharma.com
Logo: https://mma.prnewswire.com/media/1485582/Nasus_Pharma_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/nasus-pharma-anuncia-la-publicacion-de-sus-resultados-clinicos-positivos-con-el-aerosol-de-epinefrina-en-polvo-intranasal-fmxin002-en-el-journal-of-allergy-and-clinical-immunology-in-practice-301895375.html